Danica B. Stanimirovic MD, PhD

Dr. Danica Stanimirovic holds M.D. and PhD in Neurochemistry from the Faculty of Medicine, University of Belgrade. She was trained in cerebrovascular and stroke research at the Stroke Branch, NINDS, NIH. As Director of the Translational Bioscience Department, NRC’s Human Health Therapeutics Portfolio, she manages a portfolio of R&D projects in partnership with Canadian and international biotherapeutic companies aimed at de-risking and advancing biologics pipeline in preclinical development. Dr. Stanimirovic leads NRC’s Strategic Program, Therapeutics beyond Brain Barriers, focussed on development of biologics for CNS indications. She is Adjunct Professor at the Department of Cellular and Molecular Medicine, University of Ottawa and founding member of the International Brain Barriers Society. She serves on NIH review panels and Scientific Advisory Boards of biotechnology companies. Dr. Stanimirovic is recipient of several Canadian and international awards. She is an author on 129 manuscripts, 25 book chapters and 12 patents in the field of brain vascular physiology and drug delivery across the blood-brain barrier.